Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

Medimix Innovation Tracker Now Available as Real Time Data Feed

Medimix International for 2 yrs has tracked responses of more than 10,000 healthcare professionals in more than 50 countries to report on the most interesting innovations offered by the pharmaceutical and med device industries. ..new products, new delivery mechanisms, to mobile apps or differentiated commercial approaches. - July 16, 2014 - Medimix International

European Drug Pricing to Affect CMO Profitability, Future Performance

PharmSource trend report shows "battle of formulary access" expanding to U.S. - July 16, 2014 - PharmSource

CSZ Introduces New Temperature/Humidity Stability Test Chambers

Helping customers make safe & reliable products - July 12, 2014 - CSZ, A Gentherm Company

Brandsymbol Partners with Med-ERRS to Cultivate Safe Pharmaceutical Trademarks

Brandsymbol, a global branding agency, has partnered with Med-ERRS, an organization that works with the healthcare industry to prevent medication errors, in order to provide world-class pharmaceutical branding and safety testing to their clients. This partnership not only expands brandsymbol Health as leading the pharmaceutical brand creation market but also illustrates brandsymbol’s commitment to developing highly creative names that have been safety tested. - July 11, 2014 - brandsymbol

Delveinsight , a Business Consultant and Market Research Firm Released 900+ Indication and Drug Reports

The DelveInsight released reports via Pharm Delve series based on Indication and Drugs which provides Insights on Drugs, Active ingredient Intelligence, Generic/ Pipeline Intelligence and Company Intelligence. - July 11, 2014 - DelveInsight

John T. Spitznagel Has Recently Been Recognized by America’s Registry of Outstanding Professionals

John T. Spitznagel Has Recently Been Recognized by America’s Registry of Outstanding Professionals

John T. Spitznagel of Glen Burnie, Maryland has been recognized by America’s Registry of Outstanding Professionals as Professional of the Year 2014 in Healthcare Sales and Marketing. In honor of his excellent performance and achievement in his industry, he will be featured in Times Square, New York City on Friday, July 11, 2014. - July 10, 2014 - America's Registry of Outstanding Professionals

Recursion Pharmaceuticals Announces Funding for Rett Syndrome Research

Recursion Pharmaceuticals has received support for focused work to identify a treatment for Rett Syndrome by the Rett Syndrome Research Trust. Recursion will apply its innovative drug discovery platform immediately to investigate the gene MECP2 in an effort to identify new therapeutics for the condition. - July 09, 2014 - Recursion Pharmaceuticals

Igor Kaltashov, Univ. of Massachusetts-Amherst to Speak at Protein Expression Oct 23-24, 2014 Boston

Igor Kaltashov, Professor and Graduate Program Director of Chemistry at the University of Massachusetts-Amherst to Speak at Protein Expression, Purification & Characterization Conference, October 23-24, 2014 in Boston, MA. - July 05, 2014 - GTCbio

UNIVEC Announces Appointment for Chairman of Financial Advisory Board

Univec, Inc. (UNVC) a specialty pharmaceutical company, announces the appointment for Chairman of the Financial Advisory Board ("CFAB" or "Chairman") Robert M. Cohen of Revolution Investment Management based in New York. Mr. Cohen will be responsible for overseeing operations in... - July 03, 2014 - UNIVEC INC

A Lay Person's Guide to the Hobby Lobby Decision

Today, Saltbox Consulting published A Lay Person's Guide to the Hobby Lobby Decision. The guide is designed to help non-lawyers understand the Hobby Lobby decision, which the Supreme Court released on June 30, 2014. It explains in plain English what the issues were, how the Court decided them and... - July 02, 2014 - Saltbox Consulting

Q1 Productions Hosting First-Ever Pharmaceutical Supplier Quality Assurance Conference in Arlington

Supplier Visibility, Balancing Quality and Budgets Among Session Topics - June 27, 2014 - Q1 Productions

CrystalGenomics Receives KRW 13 Billion in Strategic Investment from the Global Pharmaceutical Industry Development Fund

CrystalGenomics, Inc., a late clinical stage biopharmaceutical company focused on developing and commercializing novel drugs for therapeutic areas of unmet medical needs, has just announced that it has received KRW 13 billion (USD 12.8 Million) from the Global Pharmaceutical Industry Development... - June 27, 2014 - CrystalGenomics, Inc.

Pharma Industry's Capacity to Produce Cytotoxic Injectable Drugs Constricts

PharmSource special report shows demand could tap existing CMO capacity. - June 27, 2014 - PharmSource

Serialization a Hot Topic at Upcoming Pharmaceutical Supply Chain Management Conference

Impending Serialization Requirements and End-to-End Visibility Major Discussion Focus at Second Annual Meeting - June 26, 2014 - Q1 Productions

Mayne Pharma Appoints Blake Cullen VP Business Development for U.S. Generics

He brings 15+ years of pharma industry experience in strategic planning, mergers and acquisitions, and product in-licensing and out-licensing. - June 16, 2014 - Mayne Pharma USA

Insulin Market Expected to Reach USD 32,346.7 Million in 2018 - Transparency Market Research

Transparency Market Research includes new market research report “Insulin Market" to its huge collection of research reports. - June 15, 2014 - Transparency Market Research

PlanetRx Celebrates Successful Re-Launch

PlanetRx has demonstrated improved customer satisfaction ratings with timely order fulfillment and increased offerings aimed at improving customers’ healthy lifestyles. - June 13, 2014 - PlanetRX

Markus Pompejus, VP at BASF, to Keynote at Biobased Chemicals Conf. (Sep 18-19, 2014 San Francisco)

Markus Pompejus, Vice President at BASF to Give Keynote Presentation at 5th Biobased Chemicals Commercialization & Partnering Conference (Sep 18-19, 2014 in San Francisco, CA) - June 13, 2014 - GTCbio

Photetica® Will do to the Medical Industry What Elon Musk and Tesla (TSLA) Did to the Automotive Industry

Photetica® Will do to the Medical Industry What Elon Musk and Tesla (TSLA) Did to the Automotive Industry

Photetica is now in the clinical trial phase with its game changing medical technology designed to prevent and reverse chemotherapy side effects during chemotherapy treatment at a Rochester, Minnesota based Oncology research and treatment center. - June 12, 2014 - Photetica

IonSense Introduces the DART®-EDU Program to Provide Educational Institutions with an Economical Path to Ownership of Its State-of-the-Art Mass Spectrometry Technology

Educational Leasing Program will enable chemistry departments to lower operating costs while providing students access to Direct Analysis in Real Time Mass Spectrometry. To be exhibited at the 62nd ASMS Conference on Mass Spectrometry and Allied Topics in Baltimore, MD, June 15-19, 2014, Booth 120. - June 10, 2014 - IonSense, Inc.

Strathmore’s Who’s Who Honors John T. Spitznagel as Professional of the Year

Strathmore’s Who’s Who Honors John T. Spitznagel as Professional of the Year

John T. Spitznagel has recently been recognized by Strathmore’s Who’s Who Registry for his outstanding contributions and achievements in the field of Healthcare Sales and Marketing. - June 06, 2014 - Strathmore Who's Who

Linda N. Bishop Recognized by Strathmore's Who's Who Worldwide Publication

Linda N. Bishop of Winter Haven, Florida has been included in the Strathmore’s Who’s Who Worldwide Edition for her outstanding contributions and achievements in the field of healthcare. About Linda N. Bishop Ms. Bishop has over 26 years experience in the healthcare field. She is a CRPT... - June 06, 2014 - Strathmore Worldwide

Recursion Pharmaceuticals Announces Dr. H. Perry Fell as the First Member of Business Advisory Panel

Recursion Pharmaceuticals, a biotech start-up in Salt Lake City today announced the formation of its Business Advisory Panel. The first appointment to the Advisory Panel is H. Perry Fell, MBA, Ph.D. Perry is a distinguished scientist and leader who most prominently co-founded Seattle Genetics (NASDAQ: SGEN) and served as its CEO from start-up through IPO. - June 05, 2014 - Recursion Pharmaceuticals

Solvo Biotechnology, the Transporter Company and Qualyst Transporter Solutions Execute a License to B-Clear® Services

Agreement Supporting Use of Qualyst’ s Patented B-CLEAR® Technology for Services offered by Solvo Biotechnology - May 29, 2014 - Solvo Biotechnology

Life Science Strategy Group Launches the OutsourcePharma Advisory Board

Online community dedicated to pharmaceutical sponsors provides open forum to discuss drug development and outsourced Contract Research Organization (CRO) services. - May 28, 2014 - Life Science Strategy Group, LLC

Jane Rohlf, MD & Premier Research Join Wake Research: New Investigational Site Added to Established Organization of Integrated Clinical Research Investigational Site

Raleigh-based Wake Research (Wake Research Associates, L.L.C.) announces an affiliation with Dr. Jane Rohlf and Premier Research, of Trenton, New Jersey. “Dr. Rohlf brings wealth of research expertise and her site fit well into our strategic plan to offer Biopharmaceutical Industry a broad... - May 24, 2014 - Wake Research Associates

Northeastern M.D.s to Gather for Presentation by Dr. Emil J. Haldey, Leading Pharmaceutical Compounding Expert

Northeastern M.D.s to Gather for Presentation by Dr. Emil J. Haldey, Leading Pharmaceutical Compounding Expert

The prestigious National Medical Association will host a seminar on Friday featuring Dr. Emil J. Haldey, a doctor of pharmacy and a leader in the specialized field of pharmaceutical compounding. The event will take place May 23, beginning at 2 p.m., during the National Medical Association Annual... - May 22, 2014 - HALDEY Pharmaceutical Compounding

Medcom Kinetics Launches New Web Presence

Medcom Kinetics, Inc., a content and digital applications development company offering services to the pharmaceutical, biotech, and medical devices industries has enhanced its presence on the internet by updating its corporate website’s design, content, and layout, adding a uniquely appealing... - May 18, 2014 - Medcom Kinetics, Inc.

PBS Hightens Security in Prescription Blanks

Security in prescription forms and pads is an industry ridden with fraud and drug diversion. But the prescription blanks approved vendors are fighting back to improve tamper-resistant forms and pads. - May 15, 2014 - PBS - Professional Business Systems

Meeting the Requirements of the Pharmaceutical Supply Chain Initiative Webinar

The Pharmaceutical Supply Chain Initiative (PSCI) is an initiative of the major brands in the pharmaceutical sector. PSCI is a group of pharmaceutical companies that share a vision of improved social, economic and environmental outcome for all stakeholders of the pharmaceutical supply chain, focused particularly on acceptable working conditions, safe process and facilities, economic development and a cleaner environment for local communities. - May 13, 2014 - SGS

PharmSource Lead Sheet's New Platform Adds Functionality, Dynamic Interface

Real-time resource for CROs, CMOs seeking to build market share. - May 10, 2014 - PharmSource

Xcelthera Secures Patent for Large-Scale Production High Quality Human ES Cell Therapy Products

Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute announced today that the USPTO has granted Patent No. 8,716,017 entitled “Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells”. - May 08, 2014 - Xcelthera Inc

LUZ Sponsors DA4S East Conference

Minority owned life science translation company continues support of Diversity Alliance for Science event. - May 04, 2014 - LUZ, Inc.

BiologicsCorp Launches Supernatant Protein Expression Service

BiologicsCorp Launches Supernatant Protein Expression Service

BiologicsCorp proudly launches this new service - another first in the industry. They have tested many variables, including codon optimization, strain, charperones and foldases, and others. Give Supernatant Service a try, especially if your protein of interest could not be expressed in soluble form. BiologicsCorp is confident and can guarantee success - no soluble fraction for target protein, no payment for expression service. - April 25, 2014 - BiologicsCorp

CRO Analytics Announces Free Webinar on the Use of Validated Analytics to Improve Clinical Trial Management

This free webinar will be held on Wednesday, May 14, 10AM EST. - April 18, 2014 - CRO Analytics

Clinigen Group to Manage International Named Patient Program for Abiogen Pharma’s Nerixia® (Neridronic Acid)

Clinigen Group plc (‘Clinigen’ or the ‘Group’) (AIM: CLIN) and Abiogen Pharma SpA (‘Abiogen’) jointly announced today the initiation of a Named Patient Program, managed by Clinigen Global Access Programs (Clinigen GAP) to provide Nerixia® (neridronic acid),... - April 16, 2014 - Clinigen Group

Recursion Pharmaceuticals Announces Formation of Its Scientific and Technical Advisory Board

Recursion Pharmaceuticals is a start-up biotech firm in Salt Lake City with a goal of discovering new therapeutics for the treatment of rare genetic diseases. Recursion announced the formation of its Scientific and Technical Advisory Board today, along with the appointment of Dr. Anne Carpenter and Dr. Kirk Thomas as its first two members. - April 12, 2014 - Recursion Pharmaceuticals

Pharmacovigilance Market is Expected to Reach USD 5.0 Billion Globally in 2019: Transparency Market Research

Transparency Market Research Report Adds "Pharmacovigilance Market Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. - April 12, 2014 - Transparency Market Research

Lucideon to Open Pharmaceutical Laboratories

Lucideon is pleased to announce that it has invested £1.5M in new pharmaceutical chemistry quality control (QC) testing laboratories, at its headquarters in Stoke-on-Trent. - April 10, 2014 - Lucideon

Dr. Kristy Ainslie Strengthens Drug Delivery Focus as She Becomes Advisor to Peptineo

Peptineo is pleased to welcome Dr. Ainslie to advisory board at Peptineo. Dr. Ainslie received her PhD in Chemical Engineering from Penn State, and after a short post doc in a start up company focused on biosensor development, Protiveris, she completed a post doc at UCSF. During her post doc, she... - April 08, 2014 - Peptineo

New Discussion Topics, New Speakers on Agenda for 3rd Annual Pharmaceutical Managed Markets & Payer Marketing Strategies Conference

Session Topics Include Progression of Medicare Programs and Streamlining Medical Benefit Management Process - April 05, 2014 - Q1 Productions

ALPCO Expands EuroFlow™ Product Offering with the Addition of Plasma Cell Dyscrasias Screening Tube

ALPCO Expands EuroFlow™ Product Offering with the Addition of Plasma Cell Dyscrasias Screening Tube

ALPCO has expanded EuroFlow™ product offering with addition of the Plasma Cell Screening Tube from Cytognos S.L. - April 03, 2014 - ALPCO

Global Endocrine Testing Market Projected to Reach USD 2.03 Billion by 2019: Transparency Market Research

Transparency Market Research has added a new report titled “Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” to its... - April 03, 2014 - Transparency Market Research

OsoBio Appoints Catherine Buck Director of Manufacturing

Buck has 20-plus years of experience managing pharma and commercial manufacturing plants. - April 02, 2014 - OSO BioPharmaceuticals Manufacturing, LLC

Peptineo Adds Dr. Yoganathan to Advisory Board to Strengthen Biomaterials Development and Commercialization

Dr. Yoganathan is a SME in the areas of biomaterials and drug delivery - having collaborated and worked closely with thought-leaders in the field such as Dr. Robert Langer, Dr. Kazunori Kataoka, Dr. Michael V. Sefton and Dr. Christine Allen. He is an expert in manipulating material properties to... - March 31, 2014 - Peptineo

Revolutionary Science Teaching Model Transforms Diabetes HbA1c Blood Test Into Hand-Held Education

Biologic Designs launches first crowdfunding campaign to introduce its latest educational product, the Glycated Hemoglobin A1c (HbA1c) Teaching Model. The biologic protein marker from the HbA1c blood test is no longer just a number; it is a physiological process that can be demonstrated to patients through tactile science education. - March 29, 2014 - Biologic Designs LLC

Summit Biosciences Announces Successful FDA Preapproval Inspection for Manufacturing of Nasal Spray Drug Product

Summit Biosciences Inc., a specialty pharmaceutical company, is pleased to announce that the manufacturing facility in Lexington, Kentucky has successfully passed its first preapproval inspection by the Food and Drug Administration (FDA). The inspection for a new nasal spray drug product, which... - March 28, 2014 - Summit Biosciences Inc.

Peptineo Announces Appointment of David M. Wyatt to Advisory Board

Peptineo is pleased to announce the appointment of David M. Wyatt to their advisory board. David has had over 25 years of technical and business experience in the development of controlled release pharmaceutical products. He has held senior management positions in sales and business development,... - March 27, 2014 - Peptineo

New Location, New Speakers Set for 3rd Annual Strengthening Patient Advocacy Relations Across the Life Sciences Conference

Partnering with PCORI, Building Effective Industry Alliances, Utilizing Non-Branded Patient Websites Among Discussion Topics. - March 21, 2014 - Q1 Productions

OnkoDataMed Joins ACM, ICRC-Weyer in Medis Research Group

Medis Research Group, a strategic alliance of Berlin-based clinical research organizations, has recently been joined by yet another CRO from the Berlin area, oncology specialists OnkoDataMed GmbH. - March 19, 2014 - ICRC-Weyer GmbH

Press Releases 1,551 - 1,600 of 2,765